FIA
GNOM icon

Foundations Investment Advisors’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Foundations Investment Advisors’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$625K Buy
+11,000
New +$525K 0.01% 708

Other funds holding GNOM

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
SWP
Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return
CFD
Creative Financial Designs Kokomo, Indiana $2.1B AUM 23.1% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
SH
SLT Holdings Scottsdale, Arizona $160M AUM 52.3% 1-Year Est. Return

Foundations Investment Advisors's GNOM Position: Q2 2026 in Review

Foundations Investment Advisors opened a new position in Global X Genomics & Biotechnology ETF (GNOM) in Q2 2026: 11,000 shares worth $625K. The stake represents 0.01% of the portfolio and ranks #708 among its holdings.

48 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.

  • Foundations Investment Advisors held 11,000 shares of Global X Genomics & Biotechnology ETF worth $625K as of Q2 2026.
  • Global X Genomics & Biotechnology ETF was a new Foundations Investment Advisors position in Q2 2026.
  • Global X Genomics & Biotechnology ETF made up 0.01% of Foundations Investment Advisors's portfolio in Q2 2026, its #708 holding.
  • 48 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.

Based on Foundations Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.